Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
I have almost reached my goal weight
Once-weekly GLP-1 & GIP therapy supports meaningful weight loss for patients who need more than lifestyle changes alone helping improve mobility, energy, and quality of life
Glutathione Skin whitening mesotherapy/microneedling
Some patients respond beautifully to semaglutide with fewer side effects
Este mecanismo puede ser un componente clave en la prevencin del ciclo de atracones y restricciones , que a menudo sabotea los esfuerzos por mantener un peso saludable